Consistent with this, inhibiting the CD28 pathway by genetic deficiency or blockade ameliorates autoimmunity in multiple animal models [1], while augmenting CD28 signalling by transgenic expression of its ligands can promote autoimmunity, one example being the pancreatic islet expression of CD80 in mouse models of autoimmune diabetes [2]. This evidence concerns the gene CD80 and Autoimmunity.